Chemoinformaics analysis of 4-HYDROXY-5-[(E)-3-(4-HYDROXYPHENYL)PROP-2-ENOYL]-2-METHOXYBENZALDEHYDE
| Molecular Weight | 298.294 | nRot | 5 |
| Heavy Atom Molecular Weight | 284.182 | nRig | 15 |
| Exact Molecular Weight | 298.084 | nRing | 2 |
| Solubility: LogS | -3.835 | nHRing | 0 |
| Solubility: LogP | 3.17 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 41.7351 |
| nHD | 2 | BPOL | 17.5169 |
| QED | 0.504 |
| Synth | 2.319 |
| Natural Product Likeliness | 0.769 |
| NR-PPAR-gamma | 0.458 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.009 |
| HIA | 0.01 |
| CACO-2 | -4.743 |
| MDCK | 0.0000122 |
| BBB | 0.201 |
| PPB | 0.990955 |
| VDSS | 0.423 |
| FU | 0.00763643 |
| CYP1A2-inh | 0.928 |
| CYP1A2-sub | 0.175 |
| CYP2c19-inh | 0.463 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.618 |
| CYP2c9-sub | 0.892 |
| CYP2d6-inh | 0.208 |
| CYP2d6-sub | 0.768 |
| CYP3a4-inh | 0.557 |
| CYP3a4-sub | 0.24 |
| CL | 7.999 |
| T12 | 0.875 |
| hERG | 0.062 |
| Ames | 0.929 |
| ROA | 0.446 |
| SkinSen | 0.858 |
| Carcinogencity | 0.794 |
| EI | 0.955 |
| Respiratory | 0.78 |
| NR-Aromatase | 0.778 |
| Antiviral | Yes |
| Prediction | 0.842153 |